Similar articles

• Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat and rabbit hindlimb ischemia models: preclinical study for treatment of peripheral arterial disease.

  Taniyama Y, Morishita R, Aoki M, Nakagami H, Yamamoto K, Yamazaki K, Matsumoto K, Nakamura T, Kaneda Y, Ogihara T. Taniyama Y, et al. Gene Ther. 2001 Feb;8(3):181-9. doi: 10.1038/sj.gt.3301379. Gene Ther. 2001. PMID: 11313789
• Delivery of FGF-2 but not VEGF by encapsulated genetically engineered myoblasts improves survival and vascularization in a model of acute skin flap ischemia.

  Rinsch C, Quinodoz P, Pittet B, Alizadeh N, Baetens D, Montandon D, Aebischer P, Pepper MS. Rinsch C, et al. Gene Ther. 2001 Apr;8(7):523-33. doi: 10.1038/sj.gt.3301436. Gene Ther. 2001. PMID: 11319619
• In vivo electroporation enhances plasmid-based gene transfer of basic fibroblast growth factor for the treatment of ischemic limb.

  Nishikage S, Koyama H, Miyata T, Ishii S, Hamada H, Shigematsu H. Nishikage S, et al. J Surg Res. 2004 Jul;120(1):37-46. doi: 10.1016/j.jss.2003.12.016. J Surg Res. 2004. PMID: 15172188
• [Gene therapy for peripheral arterial disease].

  Makino H, Ogihara T, Morishita R. Makino H, et al. Nihon Rinsho. 2005 Dec;63 Suppl 12:582-7. Nihon Rinsho. 2005. PMID: 16416857 Review. Japanese. No abstract available.
• Progress and prospects: naked DNA gene transfer and therapy.

  Herweijer H, Wolff JA. Herweijer H, et al. Gene Ther. 2003 Mar;10(6):453-8. doi: 10.1038/sj.gt.3301983. Gene Ther. 2003. PMID: 12621449 Review.